Vimarsana
Biggest News Aggregation in the World

Nithya Krishnamurthy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nithya Krishnamurthy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nithya Krishnamurthy Today - Breaking & Trending Today

Hematocrit Within Normal Range With Testosterone "Gender-Affirming" Therapy - Vimarsana News

Hematocrit Within Normal Range With Testosterone "Gender-Affirming" Therapy

Mean hematocrit ranged from 41.84% to 45.68% for those receiving testosterone as gender-affirming hormone therapy

Hematocrit Within Normal Range With Testosterone Gender-Affirming Therapy - Vimarsana News

Hematocrit Within Normal Range With Testosterone Gender-Affirming Therapy

A study found hematocrit within the normal range among patients taking testosterone for gender-affirming therapy.

Blood thickening tied to gender-affirming testosterone is rare - Vimarsana News

Blood thickening tied to gender-affirming testosterone is rare

Trans and gender-diverse people people who take testosterone face a risk of blood thickening, but the largest study to date in the U.S. suggests that this side effect is rare.

Hematocrit Within Normal Range With Testosterone Gender-Affirming Therapy - Vimarsana News

Hematocrit Within Normal Range With Testosterone Gender-Affirming Therapy

Mean hematocrit ranged from 41.84 to 45.68% for those receiving testosterone as gender-affirming hormone therapy.

Source: empr.com
Hormone therapy for transmasculine individuals may be safer than previously thought - Vimarsana News

Hormone therapy for transmasculine individuals may be safer than previously thought

A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis, a high concentration of red blood cells, with the use of prescribed testosterone.